aiMH Lab - Bipolar disorder prevalence and psychotropic medication

Journal article

Vanessa W S Ng, Kenneth K C Man, Le Gao, E. Chan, E. Lee, J. Hayes, I. Wong
Pharmacoepidemiology and drug safety, 2021

Semantic Scholar DOI PubMedCentral PubMed

Cite

APA Click to copy
Ng, V. W. S., Man, K. K. C., Gao, L., Chan, E., Lee, E., Hayes, J., & Wong, I. (2021). Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom. Pharmacoepidemiology and Drug Safety.

Chicago/Turabian Click to copy
Ng, Vanessa W S, Kenneth K C Man, Le Gao, E. Chan, E. Lee, J. Hayes, and I. Wong. “Bipolar Disorder Prevalence and Psychotropic Medication Utilisation in Hong Kong and the United Kingdom.” Pharmacoepidemiology and drug safety (2021).

MLA Click to copy
Ng, Vanessa W. S., et al. “Bipolar Disorder Prevalence and Psychotropic Medication Utilisation in Hong Kong and the United Kingdom.” Pharmacoepidemiology and Drug Safety, 2021.

BibTeX Click to copy

@article{vanessa2021a,
  title = {Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom},
  year = {2021},
  journal = {Pharmacoepidemiology and drug safety},
  author = {Ng, Vanessa W S and Man, Kenneth K C and Gao, Le and Chan, E. and Lee, E. and Hayes, J. and Wong, I.}
}

Abstract

Bipolar disorder (BPD) is often an under‐addressed mental disorder. Limited studies have investigated its epidemiology and drug utilisation in Hong Kong (HK) and the United Kingdom (UK) and thus local prescribing practices remain unclear. This study aimed to determine the prevalence of BPD and the prescribing of psychotropic medications as maintenance treatment from 2001–2018 in HK and the UK.